Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity

NCT04621136 is registered in ClinicalTrials.gov with Kyushu University as lead sponsor.

NCT NCT04621136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04621136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity
Lead sponsor
Kyushu University
Phase
Phase 1/2
Overall status
Completed
Start date
November 1, 2020
Completion date
December 31, 2022
Enrollment
24 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

retinopathy of prematurity